These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 30801755)
1. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics. Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755 [TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293 [No Abstract] [Full Text] [Related]
3. Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with Zhang L; Zhao L; Liu Y; Liu J; Li X J Vet Sci; 2017 Dec; 18(4):431-437. PubMed ID: 28385011 [TBL] [Abstract][Full Text] [Related]
4. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics. Ling Z; Yonghong L; Junfeng L; Li Z; Xianqiang L J Vet Pharmacol Ther; 2018 Apr; 41(2):307-313. PubMed ID: 29139136 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2. Dong Z; Zhou XZ; Sun JC; Meng XB; Li HS; Cheng FS; Wei XJ; Li B; Wang WW; Zhang JY Vet Med Sci; 2020 Feb; 6(1):105-113. PubMed ID: 31589010 [TBL] [Abstract][Full Text] [Related]
6. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease. Shryock TR; Staples JM; DeRosa DC J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390 [TBL] [Abstract][Full Text] [Related]
7. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. Blondeau JM; Fitch SD PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs. Dayao D; Gibson JS; Blackall PJ; Turni C Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882 [TBL] [Abstract][Full Text] [Related]
9. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs. Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526 [No Abstract] [Full Text] [Related]
10. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model. Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs. Hoflack G; Maes D; Mateusen B; Verdonck M; de Kruif A J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):655-64. PubMed ID: 11765801 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of porcine respiratory pathogens to tilmicosin. DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine. Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594 [TBL] [Abstract][Full Text] [Related]
15. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. Moore GM; Basson RP; Tonkinson LV Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813 [TBL] [Abstract][Full Text] [Related]
16. Determination of antibacterial agent tilmicosin in pig plasma by LC/MS/MS and its application to pharmacokinetics. Li B; Gong SY; Zhou XZ; Yang YJ; Li JY; Wei XJ; Cheng FS; Niu JR; Liu XW; Zhang JY Biomed Chromatogr; 2017 Mar; 31(3):. PubMed ID: 27564248 [TBL] [Abstract][Full Text] [Related]
17. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens. Diarra MS; Malouin F; Jacques M Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tilmicosin (Provitil powder and Pulmotil liquid AC) oral formulations in chickens. Abu-Basha EA; Idkaidek NM; Al-Shunnaq AF Vet Res Commun; 2007 May; 31(4):477-85. PubMed ID: 17225089 [TBL] [Abstract][Full Text] [Related]
19. Tilmicosin antibacterial activity and pharmacokinetics in cows. Ziv G; Shem-Tov M; Glickman A; Winkler M; Saran A J Vet Pharmacol Ther; 1995 Oct; 18(5):340-5. PubMed ID: 8587151 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tilmicosin after oral administration in swine. Shen J; Li C; Jiang H; Zhang S; Guo P; Ding S; Li X Am J Vet Res; 2005 Jun; 66(6):1071-4. PubMed ID: 16008233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]